News

In September Cengiz Akbulut was made head of the laboratory of the new Stem Cell Research University Maastricht (SCRUM). Here he discusses multiculturalism, the origin of life and his love of swing dancing.

Recently, UM’s president Rianne Letschert wrote an opinion piece for TH&MA. The journal informs managers, directors and executives at universities and colleges of higher education in both Flanders and the Netherlands about the latest trends in higher education. You can read the opinion piece here. (in Dutch)

The Brightlands Maastricht Health Campus celebrates its tenth anniversary this week. The campus now houses more than 115 companies and institutes where over 11,000 professionals and also over 11,000 students work together on valuable innovations within healthcare, medicine and life sciences.

Piet Leroy appointed professor in 'Procedural Sedation and Analgesia (PROSA) in children' at Maastricht University.

Emeritus professor Marjolein Drent received the Sarcoidosis Crystal Award for Excellence in Research and Clinical Care. She receives this international award for her achievements in the field of research and counselling of sarcoidosis patients on 24 May. This year's award is presented for the first time by the Foundation for Sarcoidosis Research (FSR), an international organisation dedicated to raising awareness and improving care for sarcoidosis patients. 

“In the field of diabetes 2 and cardiovascular disease prevention, the results of our research are a big step in the right direction."

Does personalized nutrition have positive effects on health? "The answer to this question is a resounding yes," says Ellen Blaak, professor of human biology and working at NUTRIM (School of Nutrition and Translational Research in Metabolism).

Once a refugee, she is now rector magnificus of Maastricht University. Both roles underline the importance of human rights and that’s why Pamela Habibović spoke at the opening of Maastricht Human Rights Week on 22 May.

Melissa Schepers' doctoral research at Maastricht University and Hasselt University offers hope for the development of a new medication that can halt or restore the limitations of multiple sclerosis (MS).